MX9304619A - Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion. - Google Patents

Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.

Info

Publication number
MX9304619A
MX9304619A MX9304619A MX9304619A MX9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A
Authority
MX
Mexico
Prior art keywords
interleukin
dimerica
nerves
preparation
enzyme derived
Prior art date
Application number
MX9304619A
Other languages
English (en)
Inventor
Michal Schwartz
Shoshana Eitan
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10268692A external-priority patent/IL102686A/en
Priority claimed from IL103469A external-priority patent/IL103469A0/xx
Priority claimed from IL105752A external-priority patent/IL105752A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of MX9304619A publication Critical patent/MX9304619A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención provee nuevas enzimas transglutaminasa derivada de nervios que convierte la interleucina-2 inmunoderivada a interleucina-2 dimérica que tenga una actividad citotóxica de oligodendrocitos. Una enzima de transglutinasa derivada de nervios caracterizada porque es obtenible del nervio óptico lesionado del pez que convierte la interleucina-2 (IL-2) a IL-2 dimérica que tiene actividad citotóxica para los oligondendrocitos.
MX9304619A 1992-07-30 1993-07-30 Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion. MX9304619A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL10268692A IL102686A (en) 1992-07-30 1992-07-30 Nerve-derived transglutaminase and pharmaceutical composition comprising it
IL103469A IL103469A0 (en) 1992-10-20 1992-10-20 Preparation of dimeric il-2 having oligodendrocyte cytotoxic activity and enzyme therefor
IL105752A IL105752A0 (en) 1993-05-19 1993-05-19 Preparation of dimeric il-2 having oligodendrocyte cytotoxic activity and enzyme therefor

Publications (1)

Publication Number Publication Date
MX9304619A true MX9304619A (es) 1994-05-31

Family

ID=27271570

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304619A MX9304619A (es) 1992-07-30 1993-07-30 Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.

Country Status (11)

Country Link
EP (1) EP0610475B1 (es)
JP (1) JP3310289B2 (es)
CN (1) CN1084888A (es)
AT (1) ATE214730T1 (es)
AU (1) AU667572B2 (es)
CA (1) CA2119873A1 (es)
DE (1) DE69331730T2 (es)
FI (1) FI941451A7 (es)
HU (1) HU218852B (es)
MX (1) MX9304619A (es)
WO (1) WO1994003059A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3684577B2 (ja) * 1995-06-08 2005-08-17 味の素株式会社 トランスグルタミナーゼ産生微生物のスクリーニング方法
IL125983A0 (en) * 1998-08-30 1999-04-11 Yeda Res & Dev Pharmaceutical composition comprising factor xiiia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91459A0 (en) * 1989-08-28 1990-04-29 Yeda Res & Dev Oligodendrocyte inhibitory factor
IL97365A0 (en) * 1991-02-27 1992-05-25 Yeda Res & Dev Pharmaceutical compositions comprising a lymphokine

Also Published As

Publication number Publication date
EP0610475A1 (en) 1994-08-17
FI941451A0 (fi) 1994-03-29
CA2119873A1 (en) 1994-02-17
ATE214730T1 (de) 2002-04-15
HUT70302A (en) 1995-09-28
FI941451L (fi) 1994-05-11
CN1084888A (zh) 1994-04-06
DE69331730D1 (de) 2002-04-25
FI941451A7 (fi) 1994-05-11
DE69331730T2 (de) 2002-10-31
AU667572B2 (en) 1996-03-28
JPH06511393A (ja) 1994-12-22
EP0610475B1 (en) 2002-03-20
HU218852B (hu) 2000-12-28
JP3310289B2 (ja) 2002-08-05
EP0610475A4 (en) 1997-04-23
WO1994003059A1 (en) 1994-02-17
AU4795093A (en) 1994-03-03
HU9400900D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
ES2061512T3 (es) Polipeptidos de nor-estatina y nor-cicloestatina.
AR245953A1 (es) Sistema de perhidrolisis de enzimatico para generacion in situ de peracido y procedimiento para blanquear materiales con el mismo.
EA199800662A1 (ru) Индукторы апоптоза
BR9510604A (pt) Aperfeiçoamento do rendimento de plantas
ATE404675T1 (de) Pflanzliche thioesterasen
ES2173887T3 (es) Nuevos usos farmaceuticos de las enzimas de krill.
ATE464314T1 (de) Bizyklischer lactaminhibitor des interleukin-1- beta-konvertierenden enzyms
CA2046650A1 (en) Low oil potato chip constructions
ES2043626T3 (es) Procedimiento para obtener un preparado farmaceutico.
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ATE239083T1 (de) Arabinoxylan abbauende enzymen
AU5951786A (en) Expression of enzymatically active reverse transcriptase
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
BR9510602A (pt) Aperfeiçoamento do rendimento de plantas
MX9304619A (es) Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.
DK0673425T3 (da) DNA kodning for chitin deacetylase
AU3522089A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
ES2165551T3 (es) Bacillus sp. ac13 alcalofilo y xilanasa obtenida a partir de dicha especie.
ES2053623T3 (es) Procedimiento para la preparacion de enzimas fijadas a un soporte.
AU6049390A (en) Protection of nk cell cytolytic activity in pbmc
FI870890A0 (fi) Antiglaucomafoereningar.
IT1250017B (it) Enzima immobilizzato, relativo procedimento di preparazione ed impiego
ES2039366T3 (es) Procedimiento para la resolucion enzimatica de 2-amino-1-alcanoles racemicos.
ES2141776T3 (es) Utilizacion de enzima hidrolitica para reducir o impedir los efectos secundarios de la bleomicina.
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure